There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Data availability:

ScienceOpen disciplines: Medicine, Cardiovascular Medicine

Comments

Comment on this article

Cited by 1

¿Existe un espacio para los análogos de la incretina como terapia para el sobrepeso, la obesidad y la prevención de la enfermedad cardio-metabólica?
Authors: José López-López, Karina A. Di Stefano, Elizabeth Velásquez …

See all cited by

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

Read this article at

Related collections

Karger: Digital Health

Comments

Comment on this article

Similar content 401

Cited by 1